Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s15. Available from: https://skin.dermsquared.com/skin/article/view/1168